Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease
Clinical trial NCT05136170 · COMPLETED
Trial details
- NCT number
- NCT05136170
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-27
- Primary completion
- 2023-05-24
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.